Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Axoltis Pharma

France Pepiniere Laennec, 60 Avenue Rockefeller, 69008 Lyon, France

About the sponsor

Axoltis Pharma’s clinical research is centred on Amyotrophic Lateral Sclerosis, with an emphasis on neurological disease progression and markers linked to motor neuron degeneration. The sponsor’s trial activity in ALS reflects a focused interest in the clinical and biological features of this neurodegenerative disorder.

  • Motor neuron disease
  • Neurodegeneration
  • Neuromuscular impairment

The research landscape includes work related to disease monitoring in ALS, with attention to neurological biomarkers and the underlying pathology of progressive functional decline.

About Specializations

Axoltis Pharma runs clinical trials in conditions such as Amyotrophic lateral sclerosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Amyotrophic lateral sclerosis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Glucose
  • Sponsor:Axoltis Pharma

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.